Mechanisms and treatment of extraosseous calcification in chronic kidney disease (Q37902504)

25 August 2017

1 reference

title

Mechanisms and treatment of extraosseous calcification in chronic kidney disease (English)

1 reference

25 August 2017

Markus Ketteler

1

1 reference

25 August 2017

Hansjörg Rothe

2

1 reference

25 August 2017

Thilo Krüger

3

1 reference

25 August 2017

Patrick H Biggar

4

1 reference

25 August 2017

Georg Schlieper

5

1 reference

25 August 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

Nature Reviews Nephrology

25 August 2017

1 reference

25 August 2017

7

1 reference

25 August 2017

509-516

1 reference

25 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.91

25 August 2017

0 references

cites work

Calcification and cardiovascular health: new insights into an old phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Assessment and significance of arterial stiffness in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Ultrastructural analysis of vascular calcifications in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Serum Levels of the Fetuin-Mineral Complex Correlate with Artery Calcification in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Fetuin-mineral complex reflects extraosseous calcification stress in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Fetuin-A is not associated with mortality in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Phosphate regulation of vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The emerging role of phosphate in vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Multifunctional Roles for Serum Protein Fetuin-A in Inhibition of Human Vascular Smooth Muscle Cell Calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA/2 and NMRI mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Serum magnesium level and arterial calcification in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Vitamin D receptor activators can protect against vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Role of the mouse ank gene in control of tissue calcification and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Plasma pyrophosphate and vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Treatment with pyrophosphate inhibits uremic vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

NT5E mutations and arterial calcifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Forging forward with 10 burning questions on FGF23 in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Osteoprotegerin, vascular calcification and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The mechanism of phosphorus as a cardiovascular risk factor in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Inflammation and the osteogenic regulation of vascular calcification: a review and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Vitamin K: the coagulation vitamin that became omnipotent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Sodium thiosulfate in the treatment of calcific uremic arteriolopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Sodium thiosulfate prevents vascular calcifications in uremic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.91

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

31 March 2020

1 reference

12 December 2020

Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients

1 reference

12 December 2020

Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.91

1 reference

Dimensions Publication ID

25 August 2017

0 references

1 reference